Molecular Alterations Between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor

Oncologist - United States
doi 10.1634/theoncologist.2011-0127
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

The Role and Indications of Aggressive Locoregional Therapy in Metastatic Inflammatory Breast Cancer

Scientific Reports
Multidisciplinary
2016English

Concordance of Genomic Alterations Between Primary and Recurrent Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Resection of the Primary Tumor Improves Survival in Metastatic Breast Cancer by Reducing Overall Tumor Burden

Surgery
Surgery
2013English

HPMA -Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

The Discordance of Gene Mutations Between Circulating Tumor Cells and Primary/Metastatic Tumor

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2019English

Association Between Circulating Tumor Cells and Peripheral Blood Monocytes in Metastatic Breast Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

Identification of Molecular Determinants of Primary and Metastatic Tumour Re-Initiation in Breast Cancer

Nature Cell Biology
Cell Biology
2015English

Solitary Metastatic Cauda Equina Tumor From Breast Cancer

Neurologia Medico-Chirurgica
SurgeryNeurology
2010English

Effects of Second and Subsequent Lines of Chemotherapy for Metastatic Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy